Cognizant Technology Solutions Corporation (LON:0QZ5)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,165	30,456	29,732	24,393	34,415	32,091
Market Cap Growth	4.94%	2.44%	21.89%	-29.12%	7.24%	25.15%
Enterprise Value	24,694	30,327	29,008	23,388	33,872	31,291
Last Close Price	51.50	60.86	57.81	45.25	62.19	55.60
PE Ratio	14.15	17.02	17.81	12.84	21.81	31.48
PS Ratio	1.68	1.93	1.96	1.51	2.52	2.63
PB Ratio	2.26	2.65	2.86	2.39	3.89	4.04
P/TBV Ratio	5.19	6.51	6.32	5.41	9.04	9.21
P/FCF Ratio	15.11	20.87	18.81	13.15	21.03	15.10
P/OCF Ratio	13.44	17.95	16.25	11.45	18.68	13.28
EV/Sales Ratio	1.62	1.92	1.91	1.45	2.48	2.57
EV/EBITDA Ratio	8.53	10.79	10.81	8.05	13.62	14.95
EV/EBIT Ratio	10.38	12.55	12.59	9.49	16.23	18.34
EV/FCF Ratio	14.83	20.78	18.36	12.60	20.70	14.73
Debt / Equity Ratio	0.08	0.10	0.10	0.13	0.14	0.16
Debt / EBITDA Ratio	0.30	0.40	0.36	0.41	0.45	0.56
Debt / FCF Ratio	0.52	0.82	0.67	0.69	0.75	0.61
Asset Turnover	1.06	1.03	1.07	1.09	1.06	1.00
Quick Ratio	1.97	1.76	1.95	1.88	1.87	1.73
Current Ratio	2.41	2.09	2.25	2.17	2.08	1.94
Return on Equity (ROE)	16.69%	16.21%	16.65%	18.85%	18.72%	12.74%
Return on Assets (ROA)	10.26%	9.84%	10.10%	10.39%	10.16%	8.79%
Return on Capital (ROIC)	12.57%	12.41%	12.91%	13.49%	13.45%	11.48%
Return on Capital Employed (ROCE)	18.70%	18.50%	19.40%	20.50%	19.70%	17.40%
Earnings Yield	7.07%	5.88%	5.61%	7.79%	4.59%	3.18%
FCF Yield	6.62%	4.79%	5.32%	7.61%	4.75%	6.62%
Dividend Yield	1.34%	1.59%	1.57%	1.98%	1.18%	1.16%
Payout Ratio	24.92%	26.79%	27.80%	24.63%	23.82%	34.48%
Buyback Yield / Dilution	1.10%	1.58%	2.70%	1.70%	2.40%	3.39%
Total Shareholder Return	2.44%	3.17%	4.27%	3.69%	3.58%	4.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.